-
1
-
-
0037772154
-
Long term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels
-
V. Chiantera, C. Donati Sarti, F. Fornaro, A. Ferzati, P. De Franciscis, E Sepe Long term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels Menopause 10 2003 286 291
-
(2003)
Menopause
, vol.10
, pp. 286-291
-
-
Chiantera, V.1
Donati Sarti, C.2
Fornaro, F.3
Ferzati, A.4
De Franciscis, P.5
Sepe, E.6
-
2
-
-
0029066299
-
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
-
C.J. Boushey, S.A. Beresford, G.S. Omenn, A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
-
(1995)
JAMA
, vol.274
, pp. 1049-1057
-
-
Boushey, C.J.1
Beresford, S.A.2
Omenn, G.S.3
Motulsky, A.G.4
-
3
-
-
0032056407
-
Postmenopausal oral 17b-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels
-
V. Mijatovic, P. Kenemans, C. Netelenbos, C. Jakobs, C. Popp-Snijders, E.R. Peters-Muller Postmenopausal oral 17b-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels Fertil Steril 69 1998 876 882
-
(1998)
Fertil Steril
, vol.69
, pp. 876-882
-
-
Mijatovic, V.1
Kenemans, P.2
Netelenbos, C.3
Jakobs, C.4
Popp-Snijders, C.5
Peters-Muller, E.R.6
-
4
-
-
0032870857
-
Hormone replacement therapy and plasma homocysteine levels
-
W.M. Marchien van Baal, R.G.V. Smolders, M.J. Van der Mooren, T. Teerlik, P. Kenemans Hormone replacement therapy and plasma homocysteine levels Obstet Gynecol 94 1999 485 491
-
(1999)
Obstet Gynecol
, vol.94
, pp. 485-491
-
-
Marchien Van Baal, W.M.1
Smolders, R.G.V.2
Van Der Mooren, M.J.3
Teerlik, T.4
Kenemans, P.5
-
5
-
-
0033792896
-
Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women
-
V. De Leo, A. la Marca, G. Morgante, F. Ciani, E. Zammarchi, C. Setacci Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women Am J Obstet Gynecol 183 2000 945 947
-
(2000)
Am J Obstet Gynecol
, vol.183
, pp. 945-947
-
-
De Leo, V.1
La Marca, A.2
Morgante, G.3
Ciani, F.4
Zammarchi, E.5
Setacci, C.6
-
6
-
-
0033638421
-
Failure of combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels
-
S. Eviö, A. Tiitinen, U. Turpeinen, O. Ylikorkala Failure of combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels Fertil Steril 74 2000 1081 1083
-
(2000)
Fertil Steril
, vol.74
, pp. 1081-1083
-
-
Eviö, S.1
Tiitinen, A.2
Turpeinen, U.3
Ylikorkala, O.4
-
7
-
-
0036121512
-
Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: Role of folic acid and hormone replacement therapy
-
S.E. El-Swefy, S.I. Ali, A.M. Asker, H.E. Mohamed Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats role of folic acid and hormone replacement therapy Pharm Pharmacol 54 2002 391 397
-
(2002)
Pharm Pharmacol
, vol.54
, pp. 391-397
-
-
El-Swefy, S.E.1
Ali, S.I.2
Asker, A.M.3
Mohamed, H.E.4
|